Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring "CATCH"


Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- acute venous thromboembolism,
- acute coronary syndrome
- receiving UFH therapy.

Exclusion Criteria

- non-willing to participate in the study,
- thrombolytic therapy,
- previous treatment with heparin (UFH) of more than one day before randomization,
- history of heparin-induced thrombocytopenia.
- other conditions considering by study clinians that are not suitable for the trail.